PAPER Sangerman J, Kakhniashvili D, Brown A, Shartava A, Goodman SR

Spectrin ubiquitination and oxidative stress: potential roles in blood and neurological disorders.

Cell Mol Biol Lett. 2001;6(3):607-36. PubMed.

PAPER Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y, Uchiyama Y, Hori S, Kakizuka A

VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.

Cell Death Differ. 2001 Oct;8(10):977-84. PubMed.

PAPER Popescu BO, Cedazo-Minguez A, Popescu LM, Winblad B, Cowburn RF, Ankarcrona M

Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells.

J Neurosci Res. 2001 Oct 1;66(1):122-34. PubMed.

PAPER Halliwell B

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Drugs Aging. 2001;18(9):685-716. PubMed.

PAPER Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C

Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.

Ann Neurol. 2001 Oct;50(4):434-42. PubMed.

PAPER Carter DB, Dunn E, McKinley DD, Stratman NC, Boyle TP, Kuiper SL, Oostveen JA, Weaver RJ, Boller JA, Gurney ME

Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.

Ann Neurol. 2001 Oct;50(4):468-75. PubMed.

PAPER Liu WK, Le TV, Adamson J, Baker M, Cookson N, Hardy J, Hutton M, Yen SH, Dickson DW

Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.

Ann Neurol. 2001 Oct;50(4):494-502. PubMed.

PAPER Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA

Pick's disease associated with the novel Tau gene mutation K369I.

Ann Neurol. 2001 Oct;50(4):503-13. PubMed.

PAPER Vitiello MV, Borson S

Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

CNS Drugs. 2001;15(10):777-96. PubMed.

PAPER Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.

Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30. PubMed.

PAPER Ellis KA, Nathan PJ

The pharmacology of human working memory.

Int J Neuropsychopharmacol. 2001 Sep;4(3):299-313. PubMed.

PAPER Sakaguchi M, Miyazaki M, Kondo T, Namba M

Up-regulation of S100C in normal human fibroblasts in the process of aging in vitro.

Exp Gerontol. 2001 Aug;36(8):1317-25. PubMed.

PAPER Zhang L, Xing GQ, Barker JL, Chang Y, Maric D, Ma W, Li BS, Rubinow DR

Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway.

Neurosci Lett. 2001 Oct 26;312(3):125-8. PubMed.

PAPER Sang H, Lu Z, Li Y, Ru B, Wang W, Chen J

Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.

Neurosci Lett. 2001 Oct 26;312(3):141-4. PubMed.

PAPER Abe T, Tohgi H, Murata T, Isobe C, Sato C

Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

Neurosci Lett. 2001 Oct 26;312(3):177-9. PubMed.